Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,751.60
+16.70 (0.96%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
| Generic Injectibles | 56.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Injectibles Growth | -0.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
| United States | 27.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 1.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 11.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | -3.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 10.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -2.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 4.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | -18.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 1.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | 76.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia | 742.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia Growth | 18.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Zealand | 77.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Zealand Growth | 174.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|